Expenditure Analysis of Two Year Payer Costs of Commercially Insured Type 2 Diabetes Patients Identified as Receiving Multiple Daily Injections (MDI) or Insulin Pump Therapy (CSII) Stratified by Related Diagnosis

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.1429
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Effectiveness of Insulin Pump Therapy After Transition From Multiple Daily Insulin Injections in Type 1 Diabetes

English

HbA1c Variability in Adults With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion (CSII) Therapy Compared to Multiple Daily Injection (MDI) Treatment

BMJ Open
Medicine
2019English

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2019English

Early Discontinuation and Related Treatment Costs After Initiation of Basal Insulin in Type 2 Diabetes Patients

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2015English

Three-Year Comparison of Subcutaneous Insulin Pump Treatment With Multi-Daily Injections on HbA1c, Its Variability and Hospital Burden of Children With Type 1 Diabetes

Acta Diabetologica
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2011English

Age-Specific Advantages of Continuous Subcutaneous Insulin Infusion as Compared With Multiple Daily Injections in Pediatric Patients: One-Year Follow-Up Comparison by Matched-Pair Analysis

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Adherence to Liraglutide Once Daily or Exenatide Once Weekly Over a 12-Month Period Among Commercially Insured Patients With Type 2 Diabetes Mellitus: A Retrospective Observational Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes

JAMA - Journal of the American Medical Association
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy